NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe.
In this article we summarize recommendations and guidelines for the prevention of NSF from the United States, Canada, and Europe. J. Magn. Reson. Imaging 2009;30:1357-1363. (c) 2009 Wiley-Liss, Inc.
Leiner
Tim
T
Department of Radiology, Maastricht University Medical Center Maastricht, The Netherlands. timleiner@gmail.com
Kucharczyk
Walter
W
D002170:Canada; D003287:Contrast Media / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005060:Europe; D005682:Gadolinium / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced* / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D051437:Renal Insufficiency / Q000150:complications / Q000175:diagnosis*; D014481:United States
D003287:Contrast Media; D005682:Gadolinium